Présentations scientifiques

8
Déc 2025
06:30 E.S.T.

Increased Alemtuzumab Exposure Correlates with Improved Responses in Heavily Pretreated r/r ALL patients: analysis of the BALLI-01 trial – ASH 2025

Télécharger le PDF
8
Déc 2025
06:30 E.S.T.

Trial In Progress: Open-Label Dose-Finding and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 in Subjects with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) NatHali-01_ASH 2025

Télécharger le PDF
7
Oct 2025
06:40 E.S.T.

Circularization of Single-Stranded DNA Donor Template Unleashes the Power of Non-Viral Gene Delivery for Long-Term HSCs editing – ESGCT 2025

Télécharger le PDF
7
Oct 2025
06:40 E.S.T.

Comprehensive Analysis of TALEB Off-target Editing – ESGCT 2025

Télécharger le PDF
13
Mai 2025
12:25 E.S.T.

High-fidelity C-to-T editing with TALE base editors – ASGCT 2025

Télécharger le PDF
13
Mai 2025
08:18 E.S.T.

TALEN®- Mediated non-viral Transgene Insertion for the Advancement of Cellular and Gene Therapies – ASGCT 2025

Télécharger le PDF
24
Fév 2025
12:30 E.S.T.

CAR induced expression of synthetically engineered FAP-IL2v immunocytokine ​boosts persistent anti-tumor activity of TALEN®-edited allogeneic CAR T-cells without associated IL-2 toxicity

Télécharger le PDF

Scientific publications

Discover Cellectis' scientific publications

Learn more